Sun Pharma back in favour on management talk
On Wednesday, brokerage firm Karvy put a buy' rating on Sun Pharma.17-01-2019
17-01-2019
Jefferies upgrades Sun Pharma to buy
The firm said Sun Pharma now trades below long-term valuations at 16 times FY21 earnings.16-01-2019
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kirit Valia15-01-2019
SPARC may shine on Sun Pharma royalty
Sun Pharma has made a milestone payment of $10 million to Sun Pharma Advanced Research Company as royalty for Xelprostm. Sun Pharma had earlier said i11-01-2019
Sun Pharmaceutical Industries Ltd - 524715 - Sun Pharmaceutical Industries Limited Has Informed The Exchange Regarding ''Updates''.
We refer to our press release dated September 14, 2018 regarding 'Sun Pharma and SPARC Announce US FDA Approval of XELPROS(tm) to Treat Open-angle Glaucoma or Ocular Hypertension'. Further to the above, we wish to inform you that Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, 'Sun Pharma' and includes its subsidiaries and/or associate companies) has commercialsed XELPROS (Latanoprost ophthalmic emulsion) 0.005%, in US. The Company had in-licensed XELPROS from Sun Pharma Advanced Research Company Limited ('SPARC') in June 2015 and this commercialization of XELPROS, has triggered a milestone payment of USD 10 Million and sales linked royalties, by the Company to SPARC. This is for your information and record.11-01-2019
Sun Pharma recalls about 14k cartons of anaesthesia injection
This product was distributed nationwide to wholesale customers and medical facilities09-01-2019
Acquisition may add sheen to Sun Pharma
Sun Pharma, through its subsidiary, has completed the acquisition of Japan-based Pola Pharma to strengthen its presence in the dermatology segment acr03-01-2019
Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Completion of the transaction of Pola Pharma., Japan.03-01-2019
Sun Pharma shares rally after US arm gets relief in patent infringement case
Sun Pharma shares rallied over 2 per cent in intra-day trade on Thursday after the company said its US arm had been granted relief in a patent infring27-12-2018
Year of reckoning for India Inc: Sun Pharma saw its valuations sag in 2018
Dilip Shanghvi did not disclose details of loans citing business sensitivity26-12-2018